Statements of Cash Flows (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2020	Sep. 30, 2019
CASH FLOWS FROM OPERATING ACTIVITIES
Net loss	$ (4,728,049)	$ (1,885,510)
Adjustments to reconcile net loss to net cash used in operating activities:
Stock based compensation	61,888	103,167
Fair value of options in exchange for services	642,774	399,828
Fair value of restricted stock awards issued in exchange for services	240,950	168,654
Fair value of warrants in exchange for services	53,835
Loss on Extinguishment of Debt	280,504
Amortization of debt discount	1,992,000	8,696
Common stock issued for interest expense	60,802
Change in Fair Value of Embedded Derivative		36,109
Amortization and depreciation	69,706	17,297
Changes in operating assets and liabilities:
Accounts Receivable	(21,954)	(21,042)
Deposits on Equipment		(163,090)
Inventory	(18,189)	4,020
Prepaid expenses and other current assets	(50,000)	(4,200)
Accounts payable and accrued expenses	120,498	(19,048)
Net cash used in operating activities	(1,295,235)	(1,355,119)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of Patents	(51,988)	(36,953)
Purchase of Equipment for lease	(22,578)
Capitalized Software Costs		(71,425)
Net cash used in investing activities	(74,566)	(108,378)
CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from public offering of securities, net of costs	9,023,046
Proceeds from issuance of notes payable	72,400
Repayment of bridge financing and early redemption fee	(750,000)
Proceeds from convertible debt, net of costs	1,747,203	461,307
Net cash provided by financing activities	10,092,649	461,307
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	8,722,848	(1,002,190)
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD	252,766	1,673,201
CASH AND CASH EQUIVALENTS - END OF PERIOD	8,975,614	671,011
Cash paid during the period for:
Interest	1,250
Income taxes
SUPPLEMENTAL DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Series A Convertible Preferred Stock converted to common stock		122
Common Stock issued in relation to conversion of 2020 Debentures and warrant cancellation	1,992,000
Relative fair value of common stock issued in connection with 2020 Debentures	34,412
Relative fair value of warrants issued in connection with 2020 Debentures	1,063,239
Recognition of embedded derivative liability		171,425
Beneficial conversion feature in connection with 2020 Debentures	649,552
Common stock issued in relation to Convertible Debt		70,100
Common stock cancelled	19
Cashless Exercise of Warrants		2
Common stock issued to settle accrued payroll	$ 119,041